FORMELA JEAN FRANCOIS

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$8M
Insider Sells Quantity
47
Insider Sells Sum
$211.79M

Insider Activity of FORMELA JEAN FRANCOIS

The largest purchase of all time was on 2017-11-06 and amounted to 428571 share of Spero Therapeutics, Inc. for $6M.

The largest sale of all time was on 2021-06-28 and amounted to 553376 shares of Intellia Therapeutics, Inc. for $73.45M.

Biography of FORMELA JEAN FRANCOIS

No biography is available at this moment.

2021-12-14SaleIkena Oncology, Inc.
IKNA
director
5,959
0.0217%
$14.00$83,426-63.59%
2021-12-13SaleIkena Oncology, Inc.
IKNA
director
8,330
0.0307%
$14.64$121,951-64.74%
2021-12-10SaleIkena Oncology, Inc.
IKNA
director
11,989
0.0457%
$15.03$180,195-64.33%
2021-06-28SaleIntellia Therapeutics, Inc.
NTLA
director
553,376
0.8076%
$132.73$73.45M-15.62%
2021-06-14SaleIntellia Therapeutics, Inc.
NTLA
director
170,779
0.2488%
$87.37$14.92M+28.56%
2021-06-11SaleIntellia Therapeutics, Inc.
NTLA
director
30,946
0.0454%
$85.23$2.64M+32.88%
2021-04-29SaleIntellia Therapeutics, Inc.
NTLA
director
4,513
0.0071%
$85.43$385,546+41.27%
2021-04-28SaleIntellia Therapeutics, Inc.
NTLA
director
131,926
0.1941%
$85.56$11.29M+32.61%
2021-04-27SaleIntellia Therapeutics, Inc.
NTLA
director
210,230
0.3054%
$86.22$18.13M+29.94%
2021-04-26SaleIntellia Therapeutics, Inc.
NTLA
director
806
0.0012%
$84.93$68,454+33.42%
2021-04-05SaleIntellia Therapeutics, Inc.
NTLA
director
800
0.0012%
$84.98$67,984+40.33%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
director
125,000
2.0291%
$16.00$2M-49.34%
2021-02-26SaleIntellia Therapeutics, Inc.
NTLA
director
1M
1.4901%
$60.29$60.53M+87.45%
2018-07-16SaleIntellia Therapeutics, Inc.
NTLA
director
13,372
0.0329%
$31.17$416,795-43.46%
2018-06-19SaleIntellia Therapeutics, Inc.
NTLA
director
13,372
0.0301%
$27.96$373,816-41.17%
2018-05-16SaleIntellia Therapeutics, Inc.
NTLA
director
13,372
0.0309%
$25.04$334,779-27.68%
2018-03-20SaleIntellia Therapeutics, Inc.
NTLA
director
78,490
0.1875%
$23.87$1.87M-7.66%
2017-11-06PurchaseSpero Therapeutics, Inc.
SPRO
director
428,571
5.3915%
$14.00$6M-3%
2017-07-11SaleIntellia Therapeutics, Inc.
NTLA
director
160,000
0.4527%
$16.07$2.57M+39.31%
2017-07-10SaleIntellia Therapeutics, Inc.
NTLA
director
80,000
0.2289%
$16.17$1.29M+39.73%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.